CWPWF yields 11.16% · JNJ yields 2.14%● Live data
📍 CWPWF pulled ahead of the other in Year 1
Combined, CWPWF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWPWF + JNJ for your $10,000?
Concord New Energy Group Limited, an investment holding company, engages in the generation of power in the People's Republic of China and internationally. The company operates through Power Generation, Intelligent Operation and Maintenance, and Others segments. It is involved in the investment, engineering, procurement, construction, operation, and maintenance of wind and solar power plants; and provision of design, technical, and consultancy services. The company also engages in the sale of solar and new energy equipment; design, research, and exploitation of power systems; leasing of equipment; and investment and operation of solar and wind power plants. In addition, it provides finance lease services and energy internet services. The company sells its electric power to external power grid companies. As of December 31, 2021, it had 70 grid-connected wind and photovoltaic power plants with a total installed capacity of approximately 3,708 megawatts, which include 54 wind power plants with an installed capacity of 3,313 megawatts, as well as 16 photovoltaic power plants with an installed capacity of 394 megawatts. The company was formerly known as China Windpower Group Limited and changed its name to Concord New Energy Group Limited in March 2015. The company was founded in 2006 and is based in Admiralty, Hong Kong.
Full CWPWF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.